FDA Approved: TOPIRAMATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

The FDA approved the supplemental application for Topiramate submitted by Unichem Pharmaceuticals (USA), Inc., under ANDA090162.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Migraine

Drugs mentioned

• Topiramate (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE)